BD (Becton, Dickinson and Company) (NYSE: BDX) has announced its rapid, point-of-care, SARS-CoV-2 antigen test for use on the BD Veritor™ Plus System has been CE marked to the IVD Directive (98/79/EC) ...

Becton, Dickinson and Company BDX, popularly known as BD, recently collaborated with ImageMover to provide a companion mobile app that will aid in a smoother running of SARS-CoV-2 antigen testing ...

Becton, Dickinson and Company BDX, popularly known as BD, recently collaborated with ImageMover to provide a companion mobile app that will aid in a smoother running of SARS-CoV-2 antigen testing ...

FRANKLIN LAKES, N.J., Sept. 30, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its rapid, point-of-care, SARS-CoV-2 ...

The new test reportedly delivers results in approximately 15 minutes on a portable instrument MISSISSAUGA, Ont. — BD (Becton, Dickinson and Company), a medical technology company, announced its rapid, ...

Becton, Dickinson and Company BDX, also popularly known as BD, recently received the Emergency Use Authorization (EUA) from the FDA for a rapid, point-of-care, SARS-CoV-2 diagnostic test for use with ...

Becton, Dickinson and Company BDX, also popularly known as BD, recently announced that the BD Veritor At-Home COVID-19 Test can now be purchased through several retail partners. These retail partners ...

FRANKLIN LAKES, N.J., April 1, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration ...

Becton, Dickinson and Co. (BD) on Monday said it received an order from the Dutch Ministry of Health for 9.2 million of its rapid, point-of-care, SARS-CoV-2 antigen tests for use on the BD Veritor ...